STEEL, NCT03809000: A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery |
|
|
| Active, not recruiting | 2 | 188 | Canada, US | Radiation Therapy, RT, Image-Guided Radiation Therapy (IGRT), Radiotherapy, Enzalutamide, Xtandi®, Bicalutamide, Casodex®, GnRH analog, Gonadotropin-releasing hormone analog, Lupron®, leuprolide acetate, goserelin acetate, Eligard™, Viadur™, Zoladex®, Trelstar® | RTOG Foundation, Inc., Pfizer, Astellas Pharma Inc | Prostate Cancer | 04/23 | 09/29 | | |
NCT05628363: Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer |
|
|
| Recruiting | N/A | 30 | US | Ethos Varian treatment system, Adaptive stereotactic body radiotherapy, SBRT, Androgen deprivation therapy, ADT | Washington University School of Medicine, Varian Medical Systems | Prostate Cancer, Cancer of the Prostate | 04/26 | 01/31 | | |
